Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer
Idalid Franco, MD, MPH, discusses the integration of immunotherapy, molecular biomarkers, and risk factors for recurrence into the endometrial cancer paradigm.
Idalid Franco, MD, MPH, discusses the integration of immunotherapy, molecular biomarkers, and risk factors for recurrence into the endometrial cancer paradigm.
The OncoAlert Newsletter is now out for June 23-29, 2023
2233 S Martin Luther King Dr Chicago, IL 60616 Join Healio | HemOnc Today as we celebrate the risk-takers and groundbreakers at this prestigious awards…
Exposure to certain chemicals while on the job may increase the risk of prostate cancer among firefighters, according to a recent study.
No significant difference in time to treatment was found between White and Black patients with bladder cancer, but there remained a difference in treatment outcomes.
Virtual nursing is transforming patient care and enhancing how MD Anderson supports its oncology nurses. Here’s how.
Saha A, Palchaudhuri R, Lanieri L, et al. Alloengraftment Without Significant Toxicity or GVHD in CD45 Antibody-Drug Conjugate Conditioned Fanconi Anemia Mice. Blood. 2024; (doi:…
High-intensity focused ultrasound produced noninferior salvage treatment-free survival vs radical prostatectomy in localized prostate cancer.
Wolters Kluwer (“we” or “us”) wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain…
SLS009 plus venetoclax and azacitidine elicited responses in patients with relapsed/refractory AML, particularly in those harboring ASXL1 mutations.
Analysis of long-term findings from the phase III Dana-Farber Cancer Institute Trial 05-043 showed that whole-pelvic radiation therapy was associated with favorable survival outcomes vs…